Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ModiQuest Announces Publication of Novel Antibodies

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
ModiQuest BV announced the publication of novel anti-citrullinated therapeutic antibodies for the treatment of rheumatoid arthritis.

In this publication, ModiQuest describes the discovery of novel therapeutic anti-citrullinated protein antibodies (tACPAs) that prevent the onset and/or exacerbation of inflammation and that prevent or strongly reduce the occurrence of swelling and joint damage, using a collagen antibody-induced arthritis mouse model. The ACPAs discovered by ModiQuest are directed against a citrullinated epitope in histone-2A protein in man and mouse.
 
ModiQuest has made this discovery using its proprietary antibody discovery technology platforms M-Fuse™ (highly efficient hybridoma electrofusion technology), M-Select™ (B-cell selection technology for low immunogenic or multiple antigen targets) and M-Phage™ (proprietary phase display libraries). All three technology platforms are also used by ModiQuest’s service business, ModiQuest Research BV, for custom antibody lead generation in third party service projects.
 
“The novel tACPA leads we have discovered offer a new way to contribute to the treatment of rheumatoid arthritis, and we are today in discussions with a number of pharmaceutical companies to progress the tACPA leads into clinical development”, says Dr. Jos Raats, CEO of ModiQuest. “The discovery of these antibody leads again demonstrates the huge potential of our M-Fuse™, M-Select™ and M-Phage™ technologies for the discovery of novel therapeutic and diagnostic antibodies against low-immunogenic targets.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Anti-Inflammatory Drugs Could Strengthen Airway Immunity
Mold toxins can weaken the airways' clearing mechanisms and immunity, but PKC inhibitors showed promise as a treatment.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Vaccine Against Common Cold Achievable
Researchers suggest that a vaccine against rhinoviruses is possible using variant virus vaccines.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Bacteria Use Ranking Strategy to Fight Off Viruses
Researchers have explained why microbes store virus confrontation information sequentially, with most recent attacks first.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!